Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Mutations affecting segment number and polarity in Drosophila.
The effect of vitamin a supplementation on disease progression, cytokine levels and gene expression in multiple sclerotic patients: study protocol for a randomized controlled trial.
A novel neuroprotective mechanism of riluzole: direct inhibition of protein kinase C.
Challenges and recommendations for obtaining chemical structures of industry-provided repurposing candidates.
Ligation of the jugular veins does not result in brain inflammation or demyelination in mice.
Pediatric multiple sclerosis in Venezuela.
Building a better sphingosine kinase-1 inhibitor.
Reward responsiveness and fatigue in multiple sclerosis.
Transcriptional enhancers: from properties to genome-wide predictions.
Safety, Tolerability and Efficacy of Monthly Long-acting IM Injection of 80 mg GA Depot in Subjects With RRMS
RNF and Betaseron® Tolerability Study (REFORMS)
Behçet's Disease Presenting with Acute Transverse Myelitis: MRI Findings and Review of the Nosology. A Case Report.
Deep 3D Convolutional Encoder Networks with Shortcuts for Multiscale Feature Integration Applied to Multiple Sclerosis Lesion Segmentation.
Recurrence of disease activity after repeated Natalizumab withdrawals.
[Inflammatory brain pseudotumor. A variant of demyelinating disease that simulates high-grade glioma].
Bayer Receives FDA Approval for BETACONNECT - First and Only Electronic Autoinjector in Relapsing-Remitting Multiple Sclerosis (RRMS) Treatment
Genzyme’s Lemtrada® approved in Mexico for treatment of multiple sclerosis
Study shows promising efficacy for peginterferon beta-1a in multiple sclerosis
▼Dimethyl fumarate for relapsing-remitting multiple sclerosis.
Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional study.
N-Acetylcysteine amide: A Derivative to Fulfill the Promises of N-Acetylcysteine.
Cognitive and Behavioral Outcomes in Individuals With a History of Acute Disseminated Encephalomyelitis (ADEM).
COMPARE: pharmacokinetic profiles of subcutaneous peginterferon beta-1a and subcutaneous interferon beta-1a over 2 weeks in healthy subjects.
Magnetic Resonance Phase Alterations in Multiple Sclerosis Patients with Short and Long Disease Duration.
Delta 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis.
Pages
« first
‹ previous
…
162
163
164
165
166
167
168
169
170
…
next ›
last »